Mona Shahriari, MD previews Revolutionizing Atopic Dermatitis 2025
Mona Shahriari, MD, discusses how RAD 2025 can equip providers with tools to improve atopic dermatitis outcomes.
Food Insecurity and the Dangers of Infant Formula Dilution
Nirsevimab shows strong real-world effectiveness against RSV in infants
Nirsevimab significantly reduces RSV-related hospitalizations, ICU admissions, and LRTIs in infants, but doesn’t shorten hospital stays, according to a recent study.
Demystifying Infant Formula
Full recap from the 2025 Pediatric Academic Societies meeting
In this article, we recap our top stories, expert interviews, and Q+A discussions from the 2025 Pediatric Academic Societies meeting.
Uncovering the pediatrician's role in OTC STI testing, with Lea Widdice, MD
Lea Widdice, MD, details her recent presentation at PAS 2025 on OTC STI testing within pediatrics.
